CD8A and atherosclerosis: Several human and murine studies already demonstrated accelerated immune processes after blocking or depleting PD-1 or its ligand PD-L1, with parallel increased lesional CD4+ and CD8+ T cell levels in atherosclerosis [68,91,92].